EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prescription cascades associated with acetylcholinesterase inhibitors use: a high-throughput sequence symmetry analysis

Danielle Newby, Sai Sumedha Bobba, Berta Raventós, Elin J Rowlands, Xihang Chen, Laura Molina-Porcel, Carlen Reyes, Talita Duarte-Salles iD, Antonella Delmestri iD, Wai Yi Man, Edward Burn iD, Marti Catala Sabate und 3 weitere

Age and Ageing · 01.06.2026 · 55 (6)

DOI: 10.1093/ageing/afag188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 24.06.2026. Verfasst von Danielle Newby und 14 weiteren Autor:innen. Beteiligte Einrichtung: Health Data Sciences (HDS), Translational Sciences, Botnar Research Centre, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Dementia, Drug Prescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acetylcholinesterase inhibitors (AChEIs), are commonly prescribed for dementia and can cause adverse drug events that may lead to new prescriptions, known as prescription cascades. We aimed to identify potential AChEI-induced prescription cascades using high-throughput sequence symmetry analysis (SSA).

Methods

Patients aged ≥18 years with 365 days of prior observation initiating AChEIs (donepezil, rivastigmine, or galantamine) were identified from the Clinical Practice Research Datalink GOLD (2002–2022). We screened 510 drug classes and 1213 individual ingredients initiated within ±180 days of AChEI initiation (365 days in sensitivity analyses). Crude and adjusted sequence ratios (ASRs) were calculated, and positive signals were reviewed for clinical plausibility.

Results

We identified 66 155 AChEI initiators (median age 81 years [IQR 76–85]; 62.8% female). Among ATC classes and individual ingredients, 51 and 46 signals were positive with 28 (55%) and 22 (48%) classified as potential prescription cascades after review. Gastrointestinal drugs showed positive signals including antipropulsives (ASR 1.50 [99% CI 1.28–1.75]), loperamide (ASR 1.52 [1.30–1.77]) and cyclizine (ASR 2.10 [1.72–2.59]). Positive signals were also observed nervous system drugs such as benzodiazepine derivatives (ASR 1.83 [1.55–2.16]) and respiratory drugs including corticosteroids (ASR 1.66 [1.33–2.08]) and glucocorticoids (ASR 1.54 [1.30–1.83]). Most positive signals remained in sensitivity analysis.

Conclusions

These findings suggest potential AChEI-related prescription cascades consistent with gastrointestinal, neuropsychiatric, dermatological and respiratory adverse effects. While findings require further validation, this study demonstrates the utility of high-throughput signal detection to support pharmacovigilance in high-risk populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsDementiaDrug PrescriptionsHumansFemaleMaleAged, 80 and overAgedRivastigmineDonepezilHigh-Throughput Screening Assays

Stichwörter der Autor:innen

acetylcholinesterase inhibitorsadverse drug eventsolder peoplepharmacovigilanceprescription cascadesequence symmetry analysis

Substanzen

Cholinesterase InhibitorsRivastigmineDonepezil

Autor:innen und Institutionen

  • Health Data Sciences (HDS), Translational Sciences, Botnar Research Centre, University of Oxford, Oxford, UK.
  • Health System, University of Alabama at Birmingham Birmingham, Alabama 35294, USA.
  • IDIAP Jordi Gol, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
  • Erasmus MC Universitair Medisch Centrum Rotterdam, Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, ZH, The Netherlands.
  • Biobanc de l'Hospital Clinic IDIBAPS, Neurological Tissue Bank of the Biobanc-Hospital Clinic-Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spai…
  • IDIBAPS-Alzheimer's disease and other cognitive disorders unit, Neurology Service, Hospital Clínic, Barcelona, Spain.

ORCID-Profile: Talita Duarte-Salles, Antonella Delmestri, Edward Burn, Annika M Jödicke, Daniel Prieto-Alhambra

Zitieren

APA

Newby, D., Bobba, S. S., Raventós, B., Rowlands, E. J., Chen, X., Molina-Porcel, L., Reyes, C., Duarte-Salles, T., Delmestri, A., Man, W. Y., Burn, E., Catala Sabate, M., Pratt, N., Jödicke, A. M., & Prieto-Alhambra, D. (2026). Prescription cascades associated with acetylcholinesterase inhibitors use: a high-throughput sequence symmetry analysis. Age and Ageing, 55(6). https://doi.org/10.1093/ageing/afag188

Vancouver

Newby D, Bobba SS, Raventós B, Rowlands EJ, Chen X, Molina-Porcel L, et al. Prescription cascades associated with acetylcholinesterase inhibitors use: a high-throughput sequence symmetry analysis. Age and Ageing. 2026;55(6). doi:10.1093/ageing/afag188

BibTeX
@article{Newby2026,
  author = {Newby, Danielle and Bobba, Sai Sumedha and Raventós, Berta and Rowlands, Elin J and Chen, Xihang and Molina-Porcel, Laura and Reyes, Carlen and Duarte-Salles, Talita and Delmestri, Antonella and Man, Wai Yi and Burn, Edward and Catala Sabate, Marti and Pratt, Nicole and Jödicke, Annika M and Prieto-Alhambra, Daniel},
  title = {Prescription cascades associated with acetylcholinesterase inhibitors use: a high-throughput sequence symmetry analysis},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {6},
  doi = {10.1093/ageing/afag188}
}
Kostenlos starten →